Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNew Mexico Cancer Research Alliance

About this trial

The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the Oncology Research Information Exchange Network (ORIEN) Consortium of academic medical centers, community hospital systems, and other health care providers. To bring new translational research to the community, the ORIEN consortium has initiated the ORIEN Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.

Eligibility criteria

Qualifiers

18 years of age and older.

Has a diagnosis of cancer or is suspected of having cancer.

Able to understand and sign the Informed Consent form directly.

Pregnant women are permitted to be enrolled.

Disqualifiers

Prisoners

Trial design

Treatments tested in this trial

  • Biological specimen collection

Treatment groups

No treatment groups listed

Sponsors and collaborators

New Mexico Cancer Research Alliance

Lead sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborator

Ohio State University Comprehensive Cancer Center

Collaborator